Alveron Pharma is developing a unique coagulation platform technology with the world’s first cyclodextrin-based anticoagulant reversal drug.

Alveron Pharma’s proprietary cyclodextrin-based compounds accelerate, but not initiate, coagulation via a unique mechanism. These compounds can therefore be used as systemic anti-bleeding agents, and our lead program is focused on developing a truly universal anticoagulant reversal agent.


Alveron Pharma was incorporated in March 2019 as a joint venture between Okklo Life Sciences, a company developing therapeutic cyclodextrins, and Sanquin, the Dutch Blood Supply Foundation, a world leader in coagulation research. Okklo is a privately held biopharmaceutical company developing novel therapeutic solutions in therapeutic areas with a high medical need using cyclodextrin-based technologies. The company was founded by a team of life-sciences experts previously involved in the development and approval of sugammadex (Bridion™), the first modified cyclodextrin marketed as a drug product.


Sanquin is an internationally highly respected research institute in the field of blood, transfusion, medicine and immunology, applying this knowledge to the development and manufacturing of a range of pharmaceutical and diagnostic products and services. Its core activities also comprise the safe and efficient production and distribution of blood and plasma products for the treatment of patients.

Alveron’s asset was developed jointly by Okklo and Sanquin.

Novio Tech Campus

Transistorweg 5

6534 AT Nijmegen Netherlands

More companies in this area


Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial disease.

Gatt Technologies

GATT Technologies is a privately owned, clinical-stage, medical device company.

Staten Biotechnology

Staten Biotechnology aims to develop novel and innovative strategies for the prevention of cardiovascular events, the largest unmet medical need in dyslipidemia.

SPL Medical

SPL Medical is strongly committed to improve MRI imaging to enable a much more precise, effective and patient friendly diagnosis of cancer metastasis.

QM Diagnostics

QM Diagnostics is an internationally operating, independent and innovative diagnostic microbiological laboratory.

We are specialized in health monitoring of small laboratory animals used for biomedical research.


Developing the next generation of percutaneous left ventricular assist devices.

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!